Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001640334-25-002382
Filing Date
2025-12-29
Accepted
2025-12-29 17:11:10
Documents
23

Document Format Files

Seq Description Document Type Size
1 FORM S-1 lxrp_s1.htm S-1 270658
2 LEGAL OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP lxrp_ex51.htm EX-5.1 7317
3 CONSENT lxrp_ex231.htm EX-23.1 1560
4 FILING FEE TABLE lxrp_ex107.htm   iXBRL EX-FILING FEES 27836
10 lxrp_s1img4.jpg GRAPHIC 5932
11 lxrp_s1img3.jpg GRAPHIC 5932
12 lxrp_ex51img1.jpg GRAPHIC 7046
  Complete submission text file 0001640334-25-002382.txt   477998

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20251229.xsd EX-101.SCH 5022
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20251229_lab.xml EX-101.LAB 6053
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20251229_cal.xml EX-101.CAL 898
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20251229_pre.xml EX-101.PRE 3498
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20251229_def.xml EX-101.DEF 2099
26 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_ex107_htm.xml XML 6606
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-292469 | Film No.: 251610076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)